Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 13/20 | 0.62 |
| ▸ | SMPD1 | P17405 | 5/20 | 0.60 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.53 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.50 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7107072 | 0.98 | FDPS (0.63) | FDPSSMPD1GGPS1LPAR1LPAR3 | |
| SCHEMBL7551569 | 0.88 | FDPS (0.53) | FDPSSMPD1GGPS1LPAR3 | |
| SCHEMBL5689723 | 0.88 | FDPS (0.70) | FDPSSMPD1GGPS1LPAR1LPAR3 | |
| SCHEMBL6227455 | 0.78 | FDPS (0.46) | FDPSSMPD1GGPS1 | |
| SCHEMBL3414399 | 0.77 | FDPS (1.00) | FDPSSMPD1GGPS1LPAR1LPAR3 | |
| SCHEMBL11793619 | 0.75 | FDPS (1.00) | FDPSSMPD1GGPS1LPAR1LPAR3 | |
| SCHEMBL11803650 | 0.75 | FDPS (1.00) | FDPSSMPD1GGPS1LPAR1LPAR3 | |
| SCHEMBL11773363 | 0.75 | FDPS (1.00) | FDPSSMPD1GGPS1LPAR1LPAR3 | |
| SCHEMBL4094991 | 0.75 | FDPS (1.00) | FDPSSMPD1GGPS1LPAR1LPAR3 | |
| SCHEMBL4088168 | 0.75 | FDPS (1.00) | FDPSSMPD1GGPS1LPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2000013690-A1 | EXOCYCLIC-PHOSPHOETHANOLAMINES | CLARION PHARMACEUTICALS, INC. (US) | 2000-03-16 | — | — | WO | disclosed |
| US-5804569-A | ANTIINFLAMMATORY, ANTIARRHYMIC AND LOCAL ANESTHETIC AGENT | CLARION PHARMACEUTICALS INC. (US) | 1998-09-08 | — | — | US | disclosed |